Prevalence of maternal group B streptococcal colonisation in European countries
about
Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infectionIntrapartum antibiotics for known maternal Group B streptococcal colonizationIntrapartum antibiotics for known maternal Group B streptococcal colonizationIntrapartum antibiotics for known maternal Group B streptococcal colonizationGroup B Streptococcus vaccine: state of the art'She can't come here!' Ethics and the case of birth centre admission policy in the UK.Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distributionPrevention of group B streptococcal neonatal disease revisited. The DEVANI European project.Infection of human coronary artery endothelial cells by group B streptococcus contributes to dysregulation of apoptosis, hemostasis, and innate immune responsesInvasive group B streptococcal infection in infants in Shenzhen, ChinaSevere sepsis in women with group B Streptococcus in pregnancy: an exploratory UK national case-control study.Institutional prevention policies and rates of Group B Streptococcus infection among HIV-infected pregnant women and their infants in Latin AmericaChromosomally and Extrachromosomally Mediated High-Level Gentamicin Resistance in Streptococcus agalactiaeEvaluation of the Cepheid Xpert GBS assay for rapid detection of group B Streptococci in amniotic fluids from pregnant women with premature rupture of membranes.Group B Streptococcus Colonization among Pregnant Women Attending Antenatal Care at Tertiary Hospital in Rural Southwestern Uganda.Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.Interspecies communication among commensal and pathogenic streptococci.Detection of Group B Streptococcus in Brazilian pregnant women and antimicrobial susceptibility patterns.Phenotypic and genotypic characterization of Streptococcus agalactiae in pregnant women. First study in a province of ArgentinaThe prevalence of group B streptococcus colonization in Iranian pregnant women and its subsequent outcome.Prevention of early onset group B streptococcal disease: controversial issues.Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population.Evaluation of the new brilliance GBS chromogenic medium for screening of Streptococcus agalactiae vaginal colonization in pregnant women.Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains.Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review.Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease.Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study.Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.Epidemiology of group B Streptococcus ST-17 clone in pregnant women of South Taiwan.Climate and group B streptococci colonisation during pregnancy: present implications and future concerns.Colonization prevalence and antibiotic susceptibility of Group B Streptococcus in pregnant women over a 6-year period in Dongguan, China.Group B Streptococcus detection in pregnant women via culture and PCR methods.Perinatal microbial exposure may influence aortic intima-media thickness in early infancy.Streptococcus agalactiae in pregnancies complicated by preterm prelabor rupture of membranes.Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay.Screening pregnant women for group B streptococcus infection between 30 and 32 weeks of pregnancy in a population at high risk for premature birth.Intrapartum polymerase chain reaction for detection of group B streptococcus colonisation.Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages.Early-onset group B streptococcal disease following culture-based screening in Japan: a single center study.Emergence of group B Streptococcus serotype IV in women of child-bearing age in Ireland.
P2860
Q24187315-61FD4492-0B3B-41B9-B286-CC9CC57F452BQ24194038-3E2C7825-D559-411E-A4D6-9EDCE193724CQ24201721-0E61CD96-D4CF-4A72-BA17-2BA117E30CB5Q24240155-D52015AE-AED5-4AC5-9B0C-9030CB91B6AFQ26796438-DBBCC97D-1D99-44F7-B543-A5F682BAAC63Q30361476-0396227A-900F-4E20-A8F2-38803C16F757Q33755459-A3311E77-3F28-4D00-B43B-E032FD15B0E8Q34252808-00023195-63C8-4E5D-A1E1-79144BE518D5Q34700309-FBBEF437-B3FF-4CBB-BEE4-81CAB1AF9E67Q35481809-E5141EE4-085D-4C59-A2D3-AB5E0A63DF15Q36163560-88AC544C-CDF8-400B-A223-53044A5DDCD0Q36557192-8B5E4360-5068-444C-87E4-226B66263AD7Q36644635-9AFEA5DB-BC04-4222-BE8B-395DDFB7D84FQ36884412-E95B00A8-6C92-4585-912E-906E5FBDC3EEQ36969807-35B0D8C0-B7E4-46B5-92AD-6666DCC567C0Q37074413-7C88650B-66CF-4198-A0FD-0E36BAF33569Q37074676-0CDB1DC0-FAA5-4DD8-88C8-CDD70157C19FQ37162088-38B985B3-1B8E-4B0A-BE9F-93F552BBDCB7Q37244560-D73F27A7-93AC-4B4A-81E0-B79421580BC9Q37512501-1D2B3366-B4A0-4D56-896B-D5D02BC546E7Q37589515-EB1DC0B4-B4F2-49FB-9043-D4215BE1328CQ37607132-A452D919-CB12-4E88-BF18-F4764BF7BC22Q37643479-3E87F9DF-E874-49AC-980A-E99114A1650CQ37712890-787B7124-DD54-45F6-99DF-C65EBBDC7F14Q38659683-BE3E740D-C31C-44B7-B9F8-7E203EA58966Q38844623-5D91B0F4-E980-4D08-A95A-0F81EDD4AA4DQ39155219-0FA22061-051D-42AD-8F9A-789C992D3D91Q39386700-36D02534-9D4F-47A2-B742-552859BE1C41Q39627216-0A147588-6A0C-4E51-8780-BB59F03A958CQ39729626-CEB69D9B-32F8-4121-9156-E22133C06329Q40091480-C492D4F3-0295-4764-A78E-91720FF3C68AQ40178939-9C5E32A4-A838-4140-AB09-72E6BEAC0622Q40722498-B3CA0426-B5CA-4EA9-AEB4-60980C9C6256Q41274900-751CE2B3-A782-4252-832E-78924597B13CQ42263775-71EE0501-7D1C-4432-9881-56D10DA0FBA7Q42267096-112C7210-8C5C-4D1F-876E-5F56072FCCB1Q42278905-52F7880F-8144-4450-9214-80033DB137A3Q42372557-50940DC1-C869-4EA7-AD04-2B4F1CAA61C4Q43504776-3D2E5361-1B0B-4D26-B360-872B0E3C8F60Q43670098-3CB6975B-52C5-4C30-9506-A80FB2EDFC41
P2860
Prevalence of maternal group B streptococcal colonisation in European countries
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prevalence of maternal group B streptococcal colonisation in European countries
@ast
Prevalence of maternal group B streptococcal colonisation in European countries
@en
Prevalence of maternal group B streptococcal colonisation in European countries
@nl
type
label
Prevalence of maternal group B streptococcal colonisation in European countries
@ast
Prevalence of maternal group B streptococcal colonisation in European countries
@en
Prevalence of maternal group B streptococcal colonisation in European countries
@nl
prefLabel
Prevalence of maternal group B streptococcal colonisation in European countries
@ast
Prevalence of maternal group B streptococcal colonisation in European countries
@en
Prevalence of maternal group B streptococcal colonisation in European countries
@nl
P2093
P3181
P1476
Prevalence of maternal group B streptococcal colonisation in European countries
@en
P2093
Arnoldas Bartusevicius
Egle Barcaite
Laima Maleckiene
Mindaugas Kliucinskas
Rasa Tameliene
Ruta Nadisauskiene
P304
P3181
P356
10.1080/00016340801908759
P407
P577
2008-01-01T00:00:00Z